The company projects that it will generate:
- greater than $2.1 billion of EBITDA and approximately $1.6 billion of cash from operations in a normalized macroeconomic environment before the benefit of circular investments, and
- additional EBITDA of >$500 million by 2029 through its circular initiatives:
- >$350 million of EBITDA from Kingsport, Tenn., and Longview, Texas, methanolysis projects, and
- $150 million–$200 million of EBITDA from its cellulosic biopolymer platform
The company also said it expects to generate an incremental $75 million–$100 million of EBITDA contribution in 2025 compared to 2024 from the Kingsport methanolysis facility.
Capital expenditures in 2025 are expected to be approximately $800 million. In 2026 and 2027, capital expenditures are expected to range between $800 million and $1 billion.